• Explore /
  • Poster
  • / Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a U.K. multicenter prospective study (TRACC).

Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a U.K. multicenter prospective study (TRACC).

Abstract Video & Slides Poster

Authors

Gayathri Anandappa

Gayathri Anandappa

The Royal Marsden NHS Foundation Trust, London, United Kingdom

Gayathri Anandappa , Naureen Starling , Ruwaida Begum , Annette Bryant , Shruti Sharma , Derrick Renner , Maria Aresu , Clare Peckitt , Himanshu Sethi , Andrew Feber , Vanessa Alice Potter , Marius Paraoan , Muti Abulafi , Nicol George , Graham Branagan , Sarah Duff , Nicholas West , Alexey Aleshin , Ian Chau , David Cunningham

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

NCT04050345

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 102)

DOI

10.1200/JCO.2021.39.3_suppl.102

Abstract #

102

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Susanna Slater

First Author: Noelia Tarazona

First Author: Di Cao

First Author: Anusha Chidharla